Mechanisms of resistance to antiangiogenesis therapy
Authors:
- Shaveta MehtaSMShaveta Mehta
- Adrian L. HarrisAHAdrian L. Harris
- 1 May 2010
- journal article
- review article
- Published by Elsevier in European Journal of Cancer
- Vol. 46 (8) , 1323-1332
Abstract
No abstract availableKeywords
This publication has 117 references indexed in Scilit:
- Biomarkers of response and resistance to antiangiogenic therapyNature Reviews Clinical Oncology, 2009
- Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant MetastasisCancer Cell, 2009
- A role for VEGF as a negative regulator of pericyte function and vessel maturationNature, 2008
- HIF1α Induces the Recruitment of Bone Marrow-Derived Vascular Modulatory Cells to Regulate Tumor Angiogenesis and InvasionCancer Cell, 2008
- Potential therapeutic strategies for lymphatic metastasisMicrovascular Research, 2007
- Tumour vascularization: sprouting angiogenesis and beyondCancer and Metastasis Reviews, 2007
- AZD2171, a Pan-VEGF Receptor Tyrosine Kinase Inhibitor, Normalizes Tumor Vasculature and Alleviates Edema in Glioblastoma PatientsCancer Cell, 2007
- Integrin signalling during tumour progressionNature Reviews Molecular Cell Biology, 2004
- The biology of VEGF and its receptorsNature Medicine, 2003
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisCell, 1996